via Moneycontrol Latest News https://www.moneycontrol.com/news/business/zydus’-covid-19-vaccine-shows-666-efficacyphase-3-interim-analysis-company-files-for-emergency-use_15245821.html
Zydus’ COVID-19 vaccine shows 66.6% efficacy in Phase-3 interim analysis, company files for emergency use